Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH)

CUSIP: 30050B101

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Equity / Class A Common Stock, par value $0.01 per share
Shares outstanding
112,318,617
Total 13F shares
41,564,536
Share change
+12,533,741
Total reported value
$920,662,382
Put/Call ratio
22%
Price per share
$22.30
Number of holders
131
Value change
+$288,907,012
Number of buys
81
Number of sells
47

Quarterly Holders Quick Answers

What is CUSIP 30050B101?
CUSIP 30050B101 identifies EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Pennant Capital Management, LLC
13F
Company
2.5%
2,761,721
$40,873,000 31 Dec 2016
13F
JPMORGAN CHASE & CO
13F
Company
2%
2,268,150
$33,568,000 31 Dec 2016
13F
FMR LLC
13F
Company
2%
2,242,296
$33,186,000 31 Dec 2016
13F
VANGUARD GROUP INC
13F
Company
1.9%
2,143,260
$31,721,000 31 Dec 2016
13F
Granahan Investment Management, LLC
13F
Company
1.9%
2,133,362
$31,574,000 31 Dec 2016
13F
TPG Group Holdings (SBS) Advisors, Inc.
13F
Company
1.5%
1,698,300
$25,135,000 31 Dec 2016
13F
BLAIR WILLIAM & CO/IL
13F
Company
1.4%
1,548,823
$22,923,000 31 Dec 2016
13F
TimesSquare Capital Management, LLC
13F
Company
1.2%
1,368,200
$20,249,000 31 Dec 2016
13F
PEREGRINE CAPITAL MANAGEMENT LLC
13F
Company
1.1%
1,274,376
$18,861,000 31 Dec 2016
13F
Elk Creek Partners, LLC
13F
Company
0.84%
948,783
$14,042,000 31 Dec 2016
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.61%
682,371
$10,099,000 31 Dec 2016
13F
OppenheimerFunds, Inc.
13F
Company
0.6%
679,000
$10,049,000 31 Dec 2016
13F
Alyeska Investment Group, L.P.
13F
Company
0.58%
650,000
$9,620,000 31 Dec 2016
13F
Casdin Capital, LLC
13F
Company
0.49%
555,000
$8,214,000 31 Dec 2016
13F
BlackRock Fund Advisors
13F
Company
0.44%
494,932
$7,325,000 31 Dec 2016
13F
COLUMBIA WANGER ASSET MANAGEMENT LLC
13F
Company
0.41%
460,048
$6,809,000 31 Dec 2016
13F
BlackRock Institutional Trust Company, N.A.
13F
Company
0.39%
442,412
$6,548,000 31 Dec 2016
13F
LOOMIS SAYLES & CO L P
13F
Company
0.36%
400,607
$5,929,000 31 Dec 2016
13F
UNITED SERVICES AUTOMOBILE ASSOCIATION
13F
Company
0.32%
359,090
$5,315,000 31 Dec 2016
13F
GILDER GAGNON HOWE & CO LLC
13F
Company
0.29%
329,234
$4,873,000 31 Dec 2016
13F
Pier Capital, LLC
13F
Company
0.28%
313,669
$4,642,000 31 Dec 2016
13F
PERCEPTIVE ADVISORS LLC
13F
Company
0.27%
307,800
$4,555,000 31 Dec 2016
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.27%
298,061
$4,411,000 31 Dec 2016
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.26%
296,233
$4,384,000 31 Dec 2016
13F
STATE STREET CORP
13F
Company
0.22%
250,000
$3,699,000 31 Dec 2016
13F
WADDELL & REED FINANCIAL INC
13F
Company
0.22%
247,087
$3,657,000 31 Dec 2016
13F
SYSTEMATIC FINANCIAL MANAGEMENT LP
13F
Company
0.17%
190,130
$2,814,000 31 Dec 2016
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.17%
189,534
$2,805,000 31 Dec 2016
13F
NORTHERN TRUST CORP
13F
Company
0.16%
184,748
$2,734,000 31 Dec 2016
13F
PUTNAM INVESTMENTS LLC
13F
Company
0.15%
171,349
$2,536,000 31 Dec 2016
13F
Bank of New York Mellon Corp
13F
Company
0.15%
163,884
$2,426,000 31 Dec 2016
13F
MORGAN STANLEY
13F
Company
0.14%
157,826
$2,336,000 31 Dec 2016
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.14%
154,096
$2,281,000 31 Dec 2016
13F
Invesco Ltd.
13F
Company
0.13%
146,501
$2,169,000 31 Dec 2016
13F
CITADEL ADVISORS LLC
13F
Company
0.13%
145,740
$2,157,000 31 Dec 2016
13F
DEUTSCHE BANK AG\
13F
Company
0.12%
137,346
$2,030,000 31 Dec 2016
13F
Nicholas Investment Partners, LP
13F
Company
0.12%
131,169
$1,943,000 31 Dec 2016
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.11%
126,164
$1,867,000 31 Dec 2016
13F
BARCLAYS PLC
13F
Company
0.11%
118,732
$1,757,000 31 Dec 2016
13F
MACQUARIE GROUP LTD
13F
Company
0.1%
113,011
$1,673,000 31 Dec 2016
13F
WALL STREET ASSOCIATES
13F
Company
0.1%
112,449
$1,664,000 31 Dec 2016
13F
Tygh Capital Management, Inc.
13F
Company
0.09%
105,066
$1,555,000 31 Dec 2016
13F
PANAGORA ASSET MANAGEMENT INC
13F
Company
0.09%
103,717
$1,535,000 31 Dec 2016
13F
White Pine Investment CO
13F
Company
0.09%
96,720
$1,431,000 31 Dec 2016
13F
HIGHBRIDGE CAPITAL MANAGEMENT LLC
13F
Company
0.08%
93,925
$1,390,000 31 Dec 2016
13F
DOWLING & YAHNKE LLC
13F
Company
0.08%
91,350
$1,352,000 31 Dec 2016
13F
CREDIT SUISSE AG/
13F
Company
0.08%
90,789
$1,344,000 31 Dec 2016
13F
Lombard Odier Asset Management (USA) Corp
13F
Company
0.07%
80,000
$1,184,000 31 Dec 2016
13F
Russell Investments Group, Ltd.
13F
Company
0.07%
79,579
$1,178,000 31 Dec 2016
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.07%
76,576
$1,133,000 31 Dec 2016
13F

Institutional Holders of Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) as of Q1 2017

As of 31 Mar 2017, Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) was held by 131 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 41,564,536 shares. The largest 10 holders included JPMORGAN CHASE & CO, FMR LLC, Pennant Capital Management, LLC, VANGUARD GROUP INC, Invesco Ltd., BLAIR WILLIAM & CO/IL, PERCEPTIVE ADVISORS LLC, MILLENNIUM MANAGEMENT LLC, TPG Group Holdings (SBS) Advisors, Inc., and TimesSquare Capital Management, LLC. This page lists 131 institutional shareholders reporting positions in this security for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2017 vs Q4 2016 Across Filers

Q4 2016 holders
116
Q1 2017 holders
131
Holder diff
15
Investor Q4 2016 Shares Q1 2017 Shares Share Diff Share Chg % Q4 2016 Value $ Q1 2017 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.